Strides Pharma Science Limited (STAR) reports Q2FY27 revenue at ₹14,297m, up 17% YoY; Ex-US Markets growth at 31% YoY.
Thyrocare Technologies Limited (THYROCARE) reports Q2FY27 results with revenue up 25.1% YoY, PAT before exceptional items up 25.7%.
Laurus Labs Limited (LAURUSLABS) reports strong H1 FY 2027 results with ₹4,233 Cr revenue, 31% growth, and ₹1,406 Cr EBITDA.
Max India Limited (MAXIND) announces completion of 200 homes at Noida senior living community, marking a key milestone.
Senores Pharmaceuticals Limited (SENORES) reports Q2 FY27 revenue up 25% and EBITDA +38%, driven by strong performance across markets.
Biocon Limited (NSE: BIOCON) named among Science Magazine’s Best Employers in Global Biotech and Pharma for 2026, reflecting its strong culture and social re.
Fortis Healthcare Limited acquires Suguna Hospital in Bengaluru for INR 277 crores, bolstering its network and expanding its operational bed capacity.
Zota Health Care Limited (ZOTA) reports a 54.58% YoY revenue growth and positive EBITDA for Q2FY27, highlighting strong Davaindia sales.
Syngene International Limited reports 13% sequential revenue growth in Q2 FY27, with improved operating EBITDA margin.
FDC Limited (NSE: FDC) reports strong Q2 & H1 FY27 results with revenue up 21% and EBITDA margin improving significantly.